priority News
Most Popular priority Story
Prasugrel gets priority review
The FDA has granted priority review to Eli Lilly and Daiichi Sankyo's prasugrel, an anti-clotting drug. The NDA for prasugrel was submitted to the agency in December. Now the drugmakers can expect an Read more...
Latest Headlines
- June 2, 2008
- May 9, 2008
- April 22, 2008
- March 14, 2008
- February 22, 2008
- January 3, 2008
- October 3, 2007
- July 12, 2007
- November 15, 2006
- October 26, 2006
- October 22, 2006
- September 25, 2006
- August 8, 2006
- August 6, 2006
- December 21, 2005
- November 17, 2005
- June 21, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
